Efficacy of Istradefylline, an Adenosine A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 Trials
Background: Istradefylline is a selective adenosine A 2A receptor antagonist for the treatment of patients with Parkinson’s disease (PD) experiencing OFF episodes while on levodopa/decarboxylase inhibitor. Objective: This pooled analysis of eight randomized, placebo-controlled, double-blind phase 2b...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publishing
2021-10-01
|
| Collection: | Journal of Parkinson’s Disease |
| Accès en ligne: | https://doi.org/10.3233/JPD-212672 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|